Joseph Todisco
Joseph Todisco's purchase track record
How the stock did after each of Joseph Todisco's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/13/2024 | CRMD | $51K | +28.0% | +77.2% | +7.5% |
| 9/8/2023 | CRMD | $37K | -3.8% | -0.5% | +14.9% |
| 11/15/2022 | CRMD | $76K | +17.3% | +20.9% | +3.0% |
| 8/24/2022 | CRMD | $18K | +1.5% | -0.8% | -3.6% |
| 5/16/2022 | CRMD | $34K | +14.4% | +5.8% | -1.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
AMRX Gains Fair Value Bump After Analyst Support for New Launches. Analysts have raised AMRX's fair value after backing new product launches, lifting the stock's target range. The company is listed among low‑volatility stocks that still have open questions for investors. The move comes as the shares trade near the middle of their 52‑week range and around the 53.3 RSI level.
Transaction History
| TLPH | ▲ Buy | Grant | 5,100 | $0 | 6/22/2026 | View on chart |
| CRMD | ▲ Buy | Grant | 77,156 | $0 | 2/4/2026 | View on chart |
| CRMD | ▲ Buy | Grant | 225,900 | $0 | 1/23/2026 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 27,306 | $199K | 1/23/2026 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 22,665 | $154K | 1/17/2026 | View on chart |
| CRMD | ▲ Buy | Option Exercise | 29,585 | $100K | 1/16/2026 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 17,417 | $125K | 1/12/2026 | View on chart |
| CRMD | ▲ Buy | Option Exercise | 30,000 | $133K | 12/18/2025 | View on chart |
| CRMD | ▼ Sell | Open Market | 30,000 | $360K | 12/18/2025 | View on chart |
| TLPH | ▲ Buy | Grant | 6,397 | $0 | 10/15/2025 | View on chart |
| CRMD | ▲ Buy | Option Exercise | 50,000 | $174K | 9/12/2025 | View on chart |
| CRMD | ▼ Sell | Open Market | 50,000 | $650K | 9/12/2025 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 21,225 | $247K | 5/10/2025 | View on chart |
| CRMD | ▲ Buy | Option Exercise | 59,170 | $200K | 4/1/2025 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 23,977 | $292K | 1/17/2025 | View on chart |
| CRMD | ▲ Buy | Grant | 187,500 | $0 | 1/17/2025 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 17,829 | $200K | 1/10/2025 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 26,982 | $139K | 5/10/2024 | View on chart |
| CRMD | ▲ Buy | Open Market | 13,561 | $51K | 3/13/2024 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 13,781 | $48K | 1/12/2024 | View on chart |
| CRMD | ▲ Buy | Grant | 133,333 | $0 | 1/12/2024 | View on chart |
| CRMD | ▲ Buy | Open Market | 10,000 | $37K | 9/8/2023 | View on chart |
| CRMD | ▲ Buy | Grant | 5,000 | $23K | 5/17/2023 | View on chart |
| CRMD | ▼ Sell | Tax Withholding | 37,443 | $198K | 5/10/2023 | View on chart |
| CRMD | ▲ Buy | Open Market | 20,000 | $76K | 11/15/2022 | View on chart |
| CRMD | ▲ Buy | Open Market | 4,700 | $18K | 8/24/2022 | View on chart |
| CRMD | ▲ Buy | Open Market | 10,000 | $34K | 5/16/2022 | View on chart |
| CRMD | ▲ Buy | Grant | 207,469 | $0 | 5/10/2022 | View on chart |
| AMRX | ▼ Sell | Tax Withholding | 1,562 | $5K | 5/7/2022 | View on chart |
| AMRX | ▲ Buy | Option Exercise | 4,442 | — | 5/7/2022 | View on chart |
| AMRX | ▲ Buy | Option Exercise | 11,111 | — | 3/1/2022 | View on chart |
| AMRX | ▼ Sell | Tax Withholding | 3,906 | $17K | 3/1/2022 | View on chart |
| AMRX | ▲ Buy | Option Exercise | 26,544 | — | 3/1/2022 | View on chart |
| AMRX | ▼ Sell | Tax Withholding | 9,331 | $42K | 3/1/2022 | View on chart |
| AMRX | ▲ Buy | Option Exercise | 29,684 | — | 2/27/2022 | View on chart |
| AMRX | ▼ Sell | Tax Withholding | 11,107 | $51K | 2/27/2022 | View on chart |
| AMRX | ▼ Sell | Open Market | 1,500 | $6K | 12/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
CRMD: No direct news in the last week
Recent headlines involve Actinium Pharmaceuticals, not CorMedix Inc. There are no events that directly affect CRMD’s operations or market position. Investors can continue to monitor CRMD’s own performance and broader market conditions.
CRMD: No direct news in the last week. Recent headlines involve Actinium Pharmaceuticals, not CorMedix Inc. There are no events that directly affect CRMD’s operations or market position. Investors can continue to monitor CRMD’s own performance and broader market conditions.